| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 167.13M | 252.95M | 340.92M | 385.16M | 377.40M | 362.83M |
| Gross Profit | 241.00K | -4.41M | 9.16M | 57.83M | 52.95M | 64.56M |
| EBITDA | -47.03M | -69.29M | -57.51M | 381.00K | 5.00M | -1.58M |
| Net Income | -82.98M | -105.59M | -68.30M | -49.60M | -43.39M | -38.42M |
Balance Sheet | ||||||
| Total Assets | 238.38M | 271.60M | 319.13M | 349.04M | 346.92M | 429.17M |
| Cash, Cash Equivalents and Short-Term Investments | 36.06M | 62.22M | 26.90M | 33.27M | 58.67M | 25.88M |
| Total Debt | 472.42M | 488.95M | 455.25M | 417.62M | 353.04M | 390.64M |
| Total Liabilities | 553.43M | 577.80M | 517.55M | 494.36M | 423.85M | 469.10M |
| Stockholders Equity | -322.58M | -312.06M | -206.36M | -145.32M | -76.94M | -39.93M |
Cash Flow | ||||||
| Free Cash Flow | -5.64M | -9.87M | -59.72M | -19.69M | 7.23M | -7.43M |
| Operating Cash Flow | 5.92M | 7.29M | -40.46M | -14.48M | 13.27M | 766.00K |
| Investing Cash Flow | -5.93M | -14.06M | -16.55M | -7.24M | 27.46M | -9.96M |
| Financing Cash Flow | 31.40M | 36.29M | 39.34M | -3.50M | -8.44M | -9.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
51 Neutral | HK$77.60M | -1.23 | -10.45% | 16.13% | -7.65% | -456.37% | |
46 Neutral | HK$97.20M | -8.77 | -4.08% | ― | ― | ― | |
46 Neutral | HK$751.58M | -24.49 | -5.51% | 3.20% | 3.51% | -950.83% | |
45 Neutral | HK$14.13M | 3.20 | ― | ― | -44.08% | ― | |
45 Neutral | HK$56.42M | -0.63 | -12.11% | ― | -23.51% | -5.26% | |
43 Neutral | HK$251.73M | -2.55 | ― | ― | -44.23% | 41.20% |
Teamway International Group Holdings Limited has completed a new share subscription under its general mandate, issuing 39,456,175 new shares at HK$0.341 each to a single subscriber, raising net proceeds of about HK$13.4 million earmarked for general working capital. The issuance represents roughly 10% of the company’s pre-deal share capital and 9.09% of the enlarged share base, slightly diluting existing shareholders while bringing in fresh capital and introducing a new 9.09% shareholder, with the overall ownership structure of major directors and public shareholders remaining largely intact.
The most recent analyst rating on (HK:1239) stock is a Hold with a HK$0.63 price target. To see the full list of analyst forecasts on Teamway International Group Holdings Limited stock, see the HK:1239 Stock Forecast page.
Teamway International Group Holdings Limited has entered into a subscription agreement with a Singapore-based investment and trust management company to issue 39,456,175 new shares at HK$0.341 each. This issuance represents 10% of the current share capital and aims to raise approximately HK$13.4 million for general working capital, potentially impacting the company’s financial flexibility and market positioning.
The most recent analyst rating on (HK:1239) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Teamway International Group Holdings Limited stock, see the HK:1239 Stock Forecast page.
Teamway International Group Holdings Limited, a company incorporated in the Cayman Islands, has announced the composition of its board of directors and their respective roles. The board includes executive, non-executive, and independent non-executive directors, with specific members serving on the audit, nomination, and remuneration committees. This announcement provides clarity on the governance structure of the company, which is crucial for stakeholders to understand the leadership and decision-making processes within the organization.
The most recent analyst rating on (HK:1239) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Teamway International Group Holdings Limited stock, see the HK:1239 Stock Forecast page.
Teamway International Group Holdings Limited has announced the appointment of Mr. Shiu Shu Ming as an independent non-executive director. Mr. Shiu has confirmed his independence according to the relevant rules and has no financial or other interests in the company or its subsidiaries. This appointment is part of the company’s ongoing efforts to maintain strong governance and independent oversight, which could enhance its credibility and trust among stakeholders.
The most recent analyst rating on (HK:1239) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Teamway International Group Holdings Limited stock, see the HK:1239 Stock Forecast page.
Teamway International Group Holdings Limited has announced a change in its board of directors, effective November 30, 2025. Dr. Tsang Hing Bun has resigned as an independent non-executive director to focus on other business commitments, while Mr. Shiu Shu Ming has been appointed to the same position. Mr. Shiu will also serve as the chairman of the Audit and Remuneration Committees and a member of the Nomination Committee. With extensive experience in corporate finance and involvement in the healthcare and wellness sectors, Mr. Shiu’s appointment is expected to bring valuable expertise to the company, potentially influencing its strategic direction and operations.
The most recent analyst rating on (HK:1239) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Teamway International Group Holdings Limited stock, see the HK:1239 Stock Forecast page.